571 related articles for article (PubMed ID: 6970028)
1. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
2. [Skin reactions of delayed hypersensitivity in melanoblastoma].
Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
[TBL] [Abstract][Full Text] [Related]
3. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
Catalona WJ; Tarpley JL; Potvin C; Chretien PB
Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
[TBL] [Abstract][Full Text] [Related]
4. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
Obalek S; Haftek M; Sliński W
Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
[TBL] [Abstract][Full Text] [Related]
5. [Cellular immunity indices in benign breast tumors].
Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
[TBL] [Abstract][Full Text] [Related]
6. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of the level of humoral cytotoxins and delayed hypersensitivity skin reactions with survival of patients with melanoma of the skin].
Korosteleva TA; Vagner RI; Veresova OV; Potapenkova LS
Vopr Onkol; 1983; 29(4):38-40. PubMed ID: 6858049
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
9. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
10. [Decrease in immunoreactivity in melanoma. Analysis of DNCB tests in the literature].
Remy W; Dorn R; Ulm K; Mayerhausen W
Z Hautkr; 1986 Dec; 61(24):1767-77. PubMed ID: 3825218
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
Rangel DM; Golub SH; Morton DL
Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
[TBL] [Abstract][Full Text] [Related]
12. Secondary immunodeficiency in miliary tuberculosis.
Uberoi S; Malaviya AN; Chattopadhyay C; Kumar R; Shrinivas
Clin Exp Immunol; 1975 Dec; 22(3):404-8. PubMed ID: 1083782
[TBL] [Abstract][Full Text] [Related]
13. The immunological effects of thymectomy in myasthenia gravis.
Scadding GK; Thomas HC; Havard CW
Clin Exp Immunol; 1979 May; 36(2):205-13. PubMed ID: 314366
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of immune responsiveness in human melanoma. I. Assessment of initial pretreatment status with stage of disease.
Pritchard DJ; Ritts RE; Taylor WF; Miller GC
Cancer; 1978 Jun; 41(6):2165-73. PubMed ID: 306870
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of lymphocyte subpopulations, delayed cutaneous hypersensitivity reactions and autoantibody formation in cancer patients.
Pichler WJ; Stingl G; Wagner G; Micksche M; Neumann H; Knapp W
Osterr Z Onkol; 1977 Nov; 4(5-6):110-7. PubMed ID: 202907
[No Abstract] [Full Text] [Related]
16. [Immunologic reactivity of breast cancer patients].
Semiglazov VF; Kondrat'ev VB; Mar'enko AI; L'vovich EG; Sofronov BN
Vopr Onkol; 1978; 24(8):74-9. PubMed ID: 695430
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of delayed-hypersensitivity skin tests and rosette studies in acute non-lymphoid leukemias].
Vu Van H; Révillard JP; Brochier J; Samarut C; Fière D; Révol L
Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):413-22. PubMed ID: 314098
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immunity (CMI) in psoriasis.
Gliński W; Haftek M; Obałek S; Jabłońska S
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):755-60. PubMed ID: 312084
[TBL] [Abstract][Full Text] [Related]
19. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
[TBL] [Abstract][Full Text] [Related]
20. Rosette forming T lymphocytes in healthy subjects and patients with liver disease.
Lodi TZ; Zuberi SJ
J Pak Med Assoc; 1977 Oct; 27(10):408-10. PubMed ID: 416238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
